Stockscreener 앱 받기
95.42
0.12%
0.11
시장 영업 전:
95.42
전일 마감가:
$95.31
열려 있는:
$95.48
하루 거래량:
393.38K
Relative Volume:
1.13
시가총액:
$3.16B
수익:
$2.32B
순이익/손실:
$82.93M
주가수익비율:
37.87
EPS:
2.52
순현금흐름:
$203.54M
1주 성능:
-0.86%
1개월 성능:
+4.27%
6개월 성능:
+4.86%
1년 성능:
-0.08%
1일 변동 폭
$94.88
$95.66
1주일 범위
$94.88
$96.92
52주 변동 폭
$82.15
$98.95
아메디시스 Stock (AMED) Company Profile
명칭
Amedisys Inc
전화
(225) 292-2031
주소
3854 AMERICAN WAY, BATON ROUGE, LA
AMED을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMED
Amedisys Inc
|
95.42 | 3.16B | 2.32B | 82.93M | 203.54M | 2.52 |
|
HCA
Hca Healthcare Inc
|
363.28 | 84.05B | 71.59B | 5.78B | 4.95B | 22.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
28.11 | 15.03B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
THC
Tenet Healthcare Corp
|
154.57 | 13.84B | 20.97B | 3.13B | 2.39B | 31.21 |
|
EHC
Encompass Health Corp
|
116.93 | 11.72B | 5.22B | 422.40M | 269.50M | 4.14 |
|
UHS
Universal Health Services Inc
|
191.55 | 11.48B | 15.42B | 1.03B | 956.84M | 15.02 |
아메디시스 Stock (AMED) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-29 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2024-07-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-06-07 | 다운그레이드 | Truist | Buy → Hold |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Neutral |
| 2023-03-13 | 개시 | Barclays | Equal Weight |
| 2022-10-27 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-08-02 | 다운그레이드 | UBS | Neutral → Sell |
| 2022-06-29 | 개시 | Stifel | Hold |
| 2022-06-21 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-03-01 | 업그레이드 | UBS | Sell → Neutral |
| 2022-02-25 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2022-02-25 | 재확인 | Credit Suisse | Outperform |
| 2022-02-25 | 재확인 | Oppenheimer | Outperform |
| 2022-02-25 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-02-25 | 재확인 | Raymond James | Outperform |
| 2022-02-25 | 재확인 | Truist | Buy |
| 2021-09-27 | 개시 | SVB Leerink | Mkt Perform |
| 2021-09-24 | 개시 | UBS | Sell |
| 2021-09-10 | 개시 | Cowen | Market Perform |
| 2021-08-10 | 재확인 | The Benchmark Company | Buy |
| 2021-08-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-08-20 | 재개 | Barclays | Overweight |
| 2020-07-30 | 재확인 | The Benchmark Company | Buy |
| 2020-06-18 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2020-05-07 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-03-09 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2020-01-17 | 개시 | Credit Suisse | Outperform |
| 2019-11-01 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-10-22 | 재개 | Stephens | Equal-Weight |
| 2019-09-17 | 개시 | Deutsche Bank | Buy |
| 2019-05-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-12-14 | 개시 | Barclays | Equal Weight |
| 2018-11-16 | 개시 | UBS | Neutral |
| 2018-10-30 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2018-07-03 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2018-03-19 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-11-09 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-11-09 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2017-11-08 | 재확인 | Mizuho | Buy |
| 2017-11-02 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2017-08-21 | 개시 | BofA/Merrill | Neutral |
모두보기
아메디시스 주식(AMED)의 최신 뉴스
DOJ Rejects Amedisys, UnitedHealth’s Divestiture to BrightSpring, Pennant - Hospice News
Amedisys (AMED) Faces DOJ Hurdle in UnitedHealth Deal - GuruFocus
Amedisys edges lower on report DOJ initially rejects remedy in UnitedHealth - Seeking Alpha
Amedisys Executive Makes Notable Stock Sale - TipRanks
US magistrate judge schedules UnitedHealth, Optum-Amedisys mediation conference - MLex
What Mediation Means For The UnitedHealth Group, Amedisys Deal - Home Health Care News
Director Kline Teresa L. was granted 1,690 shares, increasing direct ownership by 21% to 9,818 units (SEC Form 4) - Quantisnow
Director Capps Vickie L was granted 1,690 shares, increasing direct ownership by 21% to 9,818 units (SEC Form 4) - Quantisnow
Director Samuels Ivanetta Davis was granted 1,690 shares, increasing direct ownership by 29% to 7,600 units (SEC Form 4) - Quantisnow
UnitedHealth, Amedisys reach new deal to sell home health and hospice locations if merger approved - Healthcare Dive
Amedisys Deal Would Bring BrightSpring Into Range of New Markets - Hospice News
UnitedHealth, Amedisys strike deals to sell home care locations - Modern Healthcare
Amedisys, Inc. to Host Earnings Call - ACCESS Newswire
Amedisys to Divest Hospice, Home Health Locations to BrightSpring, The Pennant Group - Hospice News
Amedisys (AMED) Boosts Sale Prospects with Divestiture Plan - GuruFocus
Amedisys gains after announcing new divestiture agreements in UnitedHealth deal - Seeking Alpha
Decoding Amedisys Inc (AMED): A Strategic SWOT Insight - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
UnitedHealth: Q1 Decline Makes Undervalued Stock a Strong Buy With Dividend Upside - Investing.com
AMEDISYS INC SEC 10-Q Report - TradingView
AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise - TradingView
Amedisys: Q1 Earnings Snapshot - MySA
Amedisys Reports Strong Q1 2025 Financial Results - TipRanks
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
AMEDISYS Earnings Results: $AMED Reports Quarterly Earnings - Nasdaq
Amedisys Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Amedisys (AMED) Tops Q1 Earnings Estimates - Yahoo Finance
Amedisys Inc Q1 2025 Earnings: EPS of $1.84 Beats Estimates, Rev - GuruFocus
Amedisys Reports First Quarter 2025 Financial Results - The Manila Times
Amedisys Extends Credit Facility Amid Merger Talks - TipRanks
Amedisys Q1 Profit Increases, Beats Estimates - Nasdaq
Amedisys Reports First Quarter 2025 Financial Results | AMED Sto - GuruFocus
Earnings Flash (AMED) AMEDISYS INC. Reports Q1 Adjusted EPS $1.25, vs. FactSet Est of $1.11 - marketscreener.com
Amedisys, Inc. Reports Strong Q1 2025 Financial Results with Significant Revenue and Net Income Growth - Nasdaq
US settlement talks begin in UnitedHealth-Amedisys merger case - MLex
Amedisys: 2Q Earnings Snapshot - marketscreener.com
Amedisys (AMED) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
UnitedHealth to enter mediation with DOJ over Amedisys deal - Healthcare Dive
DOJ, UnitedHealth-Amedisys lawsuit headed to mediation - Modern Healthcare
DOJ's Lawsuit Against Amedisys, UnitedHealth Group Set for Mediation - Hospice News
Shareholder Alert: Ademi LLP investigates whether Amedisys, Inc. has obtained a Fair Price in its transaction with Option Care Health - marketscreener.com
Amedisys Gets Merger Filing Claim Paused In DOJ's UHG Suit - Law360
Monthly Merger Review Snapshot - Law360
Cantor Fitzgerald maintains Amedisys stock at Neutral, $101 target By Investing.com - Investing.com Canada
Lobbying Update: $50,000 of AMEDISYS HOME HEALTH AND HOSPICE CARE lobbying was just disclosed - Nasdaq
Why Is Amedisys (AMED) Up 1.3% Since Last Earnings Report? - Yahoo Finance
Amedisys’ home health volume increases by 5% for Q4 2020 as profits soar by 63% - McKnight's Senior Living
Oppenheimer moving to Perform from Not Rated on Amedisys - TipRanks
아메디시스 (AMED) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.06%
0.19%
자본화:
|
볼륨(24시간):